Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label | Annals of Internal Medicine
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? View all available purchase options and get full access to this article. Walsh BS, Sarpatwari A, Rome BN, et al. Frequency of first generic drug approvals with “skinny labels” in the United States. JAMA Intern Med. 2021;181:995-997. [PMID: 33779681] doi: 10.1001/jamainternmed.2021.0484 Walsh BS, Kesselheim AS, Sarpatwari